Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Public Health and Surveillance

Date Submitted: Apr 4, 2023

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Preventable fractions of Gastric Cancer via national screening in Asian countries 2023–40: a population-based study

  • Yushi Lin; 
  • Kailu Fang; 
  • Shuwen Li; 
  • Yang Zheng; 
  • Fenqiang Xiao; 
  • Jie Wu

ABSTRACT

Background:

The incidence of gastric cancer (GC) remains high in several Asian countries, largely due to a historical lack of national screening programs.

Objective:

As a catalyst for action, we aim to estimate the number of GC cases that could be spared in four countries in the region by 2040 if national screening interventions are introduced.

Methods:

In this population-based study, we fitted age–period–cohort models to incidence data from four Asian countries (China, Mongolia, India and Turkey) to predict the number of new GC cases between 2023 and 2040 under two scenarios. In scenario A, we assumed continued absence of national screening. In scenario B, we assumed that the implementation of GC screening starting in 2023 and the subsequent gradual impact on GC incidence would be equivalent to that observed in Korea (our comparator country) after the high-quality screening activities started in the late 2000s.

Results:

Under scenario A, the incidence of GC is expected to remain substantial in four Asian countries, with a high incidence of 66.1 per 100,000 in China. Under scenario B, the beneficial effects of national screening would increase gradually over time, leading to a halving of the predicted incidence in 2040, resulting in a range of prevented cases from nearly 2,600 in Mongolia to approximately 2.7 million in China.

Conclusions:

In countries with a high burden of GC, intensifying screening activities for early detection of precancerous lesions may be a key intervention to promote a decrease in incidence.


 Citation

Please cite as:

Lin Y, Fang K, Li S, Zheng Y, Xiao F, Wu J

Preventable fractions of Gastric Cancer via national screening in Asian countries 2023–40: a population-based study

JMIR Preprints. 04/04/2023:47871

DOI: 10.2196/preprints.47871

URL: https://preprints.jmir.org/preprint/47871

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement